| Number |
Product |
Strength |
Category |
Approval |
|
| 1 |
Acyclovir Capsules |
200mg |
Antiviral |
US FDA |
|
| 2 |
Acyclovir Tablets |
400mg、800mg |
Antiviral |
US FDA |
|
| 3 |
Anastrozole Tablets |
1mg |
Anticancer |
US FDA |
|
| 4 |
Baclofen Tablets |
10mg、20mg |
Skeletal muscle relaxants |
US FDA |
|
| 5 |
Bumetanide Tablets |
0.5mg、1mg、2mg |
Diuretics |
US FDA |
|
| 6 |
Bupropion Hydrochloride Extended-Release Tablets |
150mg、300mg |
Antidepressant |
US FDA |
|
| 7 |
Carbamazepine Extended-Release Tablets |
100mg、200mg、400mg |
Anti-seizure |
US FDA |
|
| 8 |
Celecoxib Capsules |
50mg、100mg、200mg、400mg |
Anti-inflammatory |
US FDA |
|
| 9 |
Ciprofloxacin Tablets |
250mg、500mg |
Antibiotics |
US FDA |
|
| 10 |
Felodipine ER Tablets |
2.5mg、5mg、10mg |
Cardiovascular |
US FDA |
|
| 11 |
Irbesartan Tablets |
75mg、150mg、300mg |
Cardiovascular |
US FDA |
|
| 12 |
Lamotrigine ER Tablets |
25mg、50mg、100mg、 200mg、250mg、300mg |
Antiepileptic |
US FDA |
|
| 13 |
Letrozole Tablets |
2.5mg |
Anticancer |
US FDA |
|
| 14 |
Lidocaine Injection |
1%、2%、4% |
Anesthetic |
US FDA |
|
| 15 |
Montelukast Sodium Chewable Tablets |
4mg、5mg |
Anti-inflammatory |
US FDA |
|
| 16 |
Montelukast Sodium Tablets |
10 mg |
Anti-inflammatory |
US FDA |
|
| 17 |
Memantine HCL Tablets |
5mg、10mg |
Alzheimer's Disease |
US FDA |
|
| 18 |
Midodrine HCL Tablets |
2.5mg、5mg、10mg |
Cardiovascular |
US FDA |
|
| 19 |
Paroxetine Tablets |
10mg、20mg、30mg、40mg |
Antidepressant |
US FDA |
|
| 20 |
Pregabalin Capsules |
75mg、300mg |
Antiepileptic |
US FDA |
|
| 21 |
Simvastatin Tablets |
10mg、20mg、40mg、80mg |
Cardiovascular |
US FDA |
|
| 22 |
Tamsulosin Hydrochloride Sustained-release Capsules |
0.4 mg |
Urinary system |
US FDA |
|
| 23 |
Valacyclovir Tablets |
500mg、1000mg |
Antiviral |
US FDA |
|
| 24 |
Quetiapine ER Tablets |
50mg、150mg、200 mg、300mg、400mg |
Schizophrenia |
Under US FDA review |
|
| 25 |
Avatrombopag Maleate Tablets |
20mg |
Blood system |
China NMPA |
|
| 26 |
Argatroban Injection |
2ml: 10mg |
Cardio-cerebrovascular |
China NMPA |
|
| 27 |
Alendronate Sodium Tablets |
70mg |
Osteoporosis |
China NMPA |
|
| 28 |
Baricitinib Tablets |
2mg |
Immunology |
China NMPA |
|
| 29 |
Bilastine Tablets |
20mg |
Urticaria |
China NMPA |
|
| 30 |
Bedaquiline Fumarate Tablets |
100mg |
Antituberculosis |
China NMPA |
|
| 31 |
Dapoxetine Hydrochloride Tablets |
30mg |
Premature ejaculation |
China NMPA |
|
| 32 |
Esomeprazole Sodium for Injection |
40mg |
Digestive system |
China NMPA |
|
| 33 |
Enzalutamide Soft Capsules |
40mg |
Anticancer |
China NMPA |
|
| 34 |
Ethambutol Hydrochloride, Pyrazinamide, Rifampicin and Isoniazid Tablets (Ⅱ) |
Each tablet contains Rifampicin 150 mg, Isoniazid 75 mg, Pyrazinamide 400 mg and Ethambutol Hydrochloride 275 mg |
Antituberculosis |
China NMPA |
|
| 35 |
Finerenone Tablets |
10mg |
Cardiovascular |
China NMPA |
|
| 36 |
Finasteride and Tadalafil Capsules |
Finasteride 5mg and Tadalafil 5mg |
Erectile dysfunction |
China NMPA |
|
| 37 |
Lanthanum Carbonate Chewable Tablets |
500mg |
Digestive system |
China NMPA |
|
| 38 |
Montelukast Sodium Oral Granules |
4mg |
Asthma |
China NMPA |
|
| 39 |
Minoxidil Liniment |
2% (60ml: 1.2g) 5% (60ml: 3.0g) |
Androgenetic alopecia and alopecia areata |
China NMPA |
|
| 40 |
Macitentan Tablets |
10mg |
Pulmonary Arterial Hypertension |
China NMPA |
|
| 41 |
Methimazole Tablets |
5mg、10mg |
Hyperthyroidism |
China NMPA |
|
| 42 |
Nimodipine Injection |
50ml:10mg |
Cardiovascular |
China NMPA |
|
| 43 |
Nintedanib Esylate Soft Capsules |
100mg、150mg |
Respiratory |
China NMPA |
|
| 44 |
Ornidazole Injection |
3ml: 0.5g |
Antibacterial |
China NMPA |
|
| 45 |
Pantoprazole Sodium for Injection |
40mg |
Digestive system |
China NMPA |
|
| 46 |
Policresulen Solution |
25ml(36%) |
Gynecological medication |
China NMPA |
|
| 47 |
Pantoprazole Sodium Enteric Capsules |
40mg |
Digestive system |
China NMPA |
|
| 48 |
Pramipexole Dihydrochloride Sustained-release Tablets |
0.375mg、0.75mg |
Nervous |
China NMPA |
|
| 49 |
Perampanel Tablets |
2mg、4mg |
Seizure |
China NMPA |
|
| 50 |
Regorafenib Tablets |
40mg |
Anticancer |
China NMPA |
|
| 51 |
Rivastigmine Tartrate Capsules |
1.5mg、3.0mg |
Nervous |
China NMPA |
|
| 52 |
Rupatadine Fumarate Tablets |
10mg |
Antiallergic |
China NMPA |
|
| 53 |
Rifampicin and Isoniazid Tablets |
300mg/150mg |
Antituberculosis |
China NMPA |
|
| 54 |
Rifampicin Capsules |
300mg、150mg |
Antituberculosis |
China NMPA |
|
| 55 |
Sildenafil Citrate Orodispersible Tablets |
50mg |
Erectile dysfunction |
China NMPA |
|
| 56 |
Sildenafil Citrate Tablets |
20mg |
Pulmonary Arterial Hypertension |
China NMPA |
|
| 57 |
Sildenafil Citrate Tablets |
100mg |
Erectile Dysfunction |
China NMPA |
|
| 58 |
Tadalafil Tablets |
5mg |
Erectile dysfunction |
China NMPA |
|
| 59 |
Atropine Sulfate Eye Drops |
1%(0.4ml:4mg) |
Ophthalmic |
To be submitted in Mar.2025 |
|
| 60 |
Brexpiprazole Tablets |
0.5mg、1mg、2mg |
Schizophrenia |
Approved by China NMPA in 2026 |
|
| 61 |
Compound Sodium Sulfate Tablets |
Each tablet contains Sodium Sulfate 1.479 g, Magnesium Sulfate (calculated as MgSO4) 0.225 g, Potassium Chloride 0.188 g |
Digestive system |
Approved by China NMPA in 2026 |
|
| 62 |
Cyclosporin Eye Drops (Ⅲ) |
0.1%(0.3ml:0.3mg) |
Ophthalmic |
To be submitted in Apr.2025 |
|
| 63 |
Cyclosporin Eye Drops (II) |
0.05%(0.4ml:0.2mg) |
Ophthalmic |
Submitted to US FDA in Jan.2024 |
|
| 64 |
Diquafosol Sodium Eye Drops |
3%(5ml:150mg) |
Dry Eye Disease |
Approved by China NMPA in 2026 |
|
| 65 |
Dienogest Tablets |
2mg |
Contraceptives |
Approved by China NMPA in 2027 |
|
| 66 |
Glucosamine Sulfate Capsules |
0.25 g (calculated as glucosamine sulfate) or 0.314 g (calculated as glucosamine sulfate sodium chloride salt) |
Osteoarthritis |
Approved by China NMPA in 2027 |
|
| 67 |
Indobufen Tablets |
0.2g |
thromboembolic diseases |
Approved by China NMPA in 2027 |
|
| 68 |
Labetalol Hydrochloride Tablets |
100mg、200mg |
Cardiovascular |
Approved by China NMPA in 2026 |
|
| 69 |
Lidocaine Prilocaine Cutaneous spray solution |
Each bottle contains 110 actuations. Each actuation delivers 7.5 mg lidocaine and 2.5 mg prilocaine |
Primary premature ejaculation in adult males |
Approved by China NMPA in 2027 |
|
| 70 |
Lidocaine and Prilocaine Cream |
5 g: Lidocaine 125 mg and Prilocaine 125 mg |
Local anesthetic |
To be submitted in Apr.2025 |
|
| 71 |
Montmorillonite Suspension |
3g、10g |
Gastrointestinal |
Approved by China NMPA in 2026 |
|
| 72 |
Mesalamine Extended Release Capsules |
375mg |
Digestive system |
Submitted to US FDA in Feb.2023 |
|
| 73 |
Polidocanol Injection |
2ml:20mg |
Varicose Veins |
Approved by China NMPA in 2026 |
|
| 74 |
Pilocarpine Hydrochloride Eye Drops |
1.25%(2.5ml:31.25mg) |
Ophthalmic |
Approved by China NMPA in 2027 |
|
| 75 |
Pretomanid Tablets |
200mg |
Antituberculosis |
Approved by China NMPA in 2028 |
|
| 76 |
Rifaximin Tablets |
200mg、550mg |
Antibacterial |
To be submitted in Q4.2025 |
|
| 77 |
Safinamide Mesylate Tablets |
50mg、100mg |
Parkinson's disease |
Approved by China NMPA in 2027 |
|
| 78 |
Budesonide Enteric-coated Capsules |
4mg |
Gastrointestinal anti-inflammatory |
R&D |
|
| 79 |
Citrus Bioflavonoids Tablets |
0.5g |
Cardiovascular |
R&D |
|
| 80 |
Cisplatin Polymeric Micelles for Injection |
50mg |
Anticancer |
R&D |
|
| 81 |
Diclofenac Sodium Dual Release Enteric-coated Capsules |
100mg、75mg |
Anti-inflammatory |
R&D |
|
| 82 |
Gliclazide Tablets (II) |
80mg |
Diabetes |
R&D |
|
| 83 |
Insulin Icodec |
700 IU/mL |
diabetes |
R&D |
|
| 84 |
Lithium Carbonate Sustained-release Tablets |
300mg |
Psychiatric |
R&D |
|
| 85 |
Morphine Sulfate Sustained-release Tablets |
10mg、30mg、60mg |
Analgesic |
R&D |
|
| 86 |
Nifuratel and Nystatin Vaginal Soft Capsules |
0.5 g × 20,000 Units |
Vaginitis |
R&D |
|
| 87 |
Propranolol Hydrochloride Sustained-release Capsules |
60mg、80mg |
Cardiovascular |
R&D |
|
| 88 |
Paclitaxel Polymeric Micelles for Injection |
30mg |
Anticancer |
R&D |
|
| 89 |
Romiplostim |
250g |
Blood system |
R&D |
|
| 90 |
Paclitaxel For Injection(Albumin Bound) |
100mg |
Anticancer |
TBD |
|